Skip to Content

Diseases, Volume 3, Issue 4

2015 December - 10 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (10)

  • Review
  • Open Access
22 Citations
8,339 Views
34 Pages

17 December 2015

Prader-Willi syndrome (PWS) is a neurodevelopmental disorder of genomic imprinting, presenting with a behavioural phenotype encompassing hyperphagia, intellectual disability, social and behavioural difficulties, and propensity to psychiatric illness....

(This article belongs to the Special Issue Prader-Willi Syndrome)
  • Review
  • Open Access
43 Citations
6,654 Views
22 Pages

Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future

  • Masafumi Ikeda,
  • Shuichi Mitsunaga,
  • Izumi Ohno,
  • Yusuke Hashimoto,
  • Hideaki Takahashi,
  • Kazuo Watanabe,
  • Kumiko Umemoto and
  • Takuji Okusaka

1 December 2015

Systemic chemotherapy is one of the most important treatment modalities for advanced hepatocellular carcinoma (HCC). Before the introduction of sorafenib, cytotoxic agents, hormonal therapies, or many combinations of these were the mainly used modali...

(This article belongs to the Special Issue Targeted Therapy of Hepatocellular Carcinoma: Present and Future)
  • Review
  • Open Access
9 Citations
8,373 Views
19 Pages

6 November 2015

Recently, metagenomics and metabolomics are the two most rapidly advancing “omics” technologies. Metagenomics seeks to characterize the composition of microbial communities, their operations, and their dynamically co-evolving relationships with the h...

  • Review
  • Open Access
6 Citations
7,531 Views
16 Pages

New Tools for Molecular Therapy of Hepatocellular Carcinoma

  • Alessandra Marchetti,
  • Francesca Bisceglia,
  • Angela M. Cozzolino and
  • Marco Tripodi

30 October 2015

Hepatocellular carcinoma (HCC) is the most common type of liver cancer, arising from neoplastic transformation of hepatocytes or liver precursor/stem cells. HCC is often associated with pre-existing chronic liver pathologies of different origin (main...

(This article belongs to the Special Issue Targeted Therapy of Hepatocellular Carcinoma: Present and Future)
  • Review
  • Open Access
62 Citations
13,628 Views
12 Pages

28 October 2015

Hepatocellular carcinoma (HCC) is a lethal cancer with limited systemic therapeutic options. Liver carcinogenesis is a complex procedure and various pathways have been found to be deregulated which are potential targets for novel treatments. Aberrant...

(This article belongs to the Special Issue Targeted Therapy of Hepatocellular Carcinoma: Present and Future)
  • Review
  • Open Access
8 Citations
6,874 Views
19 Pages

Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma

  • Joycelyn J. X. Lee,
  • Jack J. Chan and
  • Su Pin Choo

28 October 2015

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death. In patients with advanced or unresectable HCC, there are few treatment options. Conventional chemotherapy has limited benefits. Sorafenib, a multi-kinase inhibitor, improve...

(This article belongs to the Special Issue Targeted Therapy of Hepatocellular Carcinoma: Present and Future)
  • Review
  • Open Access
31 Citations
11,893 Views
12 Pages

27 October 2015

Celiac disease (CD) is a systemic immune-mediated disorder caused by the ingestion of gluten-containing grains in genetically susceptible persons. It is one of the most common lifelong disorders, affecting approximately 1% of the general population...

(This article belongs to the Special Issue Celiac Disease)
  • Review
  • Open Access
25 Citations
8,065 Views
22 Pages

22 October 2015

Hepatocellular carcinoma (HCC) is highly resistant to currently available chemotherapeutic agents. The clinical outcome of HCC treatment remains unsatisfactory. Therefore, new effective and well-tolerated therapy strategies are needed. Natural produc...

(This article belongs to the Special Issue Targeted Therapy of Hepatocellular Carcinoma: Present and Future)
  • Article
  • Open Access
9 Citations
6,990 Views
7 Pages

16 October 2015

Vitamin D has several extra calcemic effects. Vitamin D deficiency is highly prevalent in chronic obstructive pulmonary disease (COPD) patients but little is known about it’s association with lung function. Objective: To investigate whether supplemen...

  • Review
  • Open Access
2 Citations
12,518 Views
32 Pages

A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma

  • Claire Faltermeier,
  • Ronald W. Busuttil and
  • Ali Zarrinpar

29 September 2015

Hepatocellular carcinoma (HCC), the second leading cause of cancer deaths worldwide, is difficult to treat and highly lethal. Since HCC is predominantly diagnosed in patients with cirrhosis, treatment planning must consider both the severity of liver...

(This article belongs to the Special Issue Targeted Therapy of Hepatocellular Carcinoma: Present and Future)
XFacebookLinkedIn
Diseases - ISSN 2079-9721